PedAM
Pediatric Disease Annotations & Medicines
| Disease | polycystic ovary syndrome |
| Symptom | C0007222|cardiovascular disease |
| Sentences | 12 |
| PubMedID- 23362921 | cardiovascular disease in polycystic ovary syndrome. |
| PubMedID- 20375205 | Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (ae-pcos) society. |
| PubMedID- 20536945 | Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced. |
| PubMedID- 25878664 | Predictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: interrelationship of dyslipidemia and arterial blood pressure. |
| PubMedID- 22995747 | polycystic ovary syndrome (pcos) is associated with increased cardiovascular disease risk. |
| PubMedID- 21717407 | Background: the increased incidence of cardiovascular disease in women with polycystic ovary syndrome (pcos) has prompted researchers to look for indicators of early atherosclerotic changes in these patients. |
| PubMedID- 24528623 | Background: polycystic ovary syndrome (pcos) is associated with an increased cardiovascular disease (cvd) risk and early atherosclerosis. |
| PubMedID- 23318877 | polycystic ovary syndrome (pcos) is associated with cardiovascular disease. |
| PubMedID- 26288196 | The incidence of cardiovascular disease (cvd) in patients with polycystic ovary syndrome (pcos) is very high and conventional risk factors only partially explain excessive risk of developing cvd in patients of pcos. |
| PubMedID- 26104466 | Conclusion: the lipid accumulation product seems to be sufficient to indicate a risk of cardiovascular diseases in women with polycystic ovary syndrome. |
| PubMedID- 21547513 | cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes. |
| PubMedID- 22703625 | The aim of this study was to assess relationship of insulin resistance, oxidant-antioxidant status, endothelial dysfunction, lipid metabolism, and their contribution to the risks of cardiovascular disease in women with polycystic ovary syndrome (pcos). |
Page: 1